ANTIBODY-RESPONSE TO MEASLES IMMUNIZATION IN INDIA
- 1 January 1984
- journal article
- research article
- Vol. 62 (5) , 737-741
Abstract
Antibody response to measles vaccine was measured in 238 subjects aged 6-15 mo. Seroconversion rates ranged from 74% at 6 mo. of age to 100% at 13-15 mo.; the differences in age-specific rates were not statistically significant. The postimmunization antibody titers increased with increasing age of the vaccinee. Seroconversion rates and antibody titers in 49 subjects with grades I and II malnutrition were not significantly different from those in the 189 normal subjects. These results support the recommendation of 9 mo. as a satisfactory age for commencement of measles immunization in India. The highest antibody levels and seroconversion rates were obtained in children > 12 mo. of age.This publication has 18 references indexed in Scilit:
- MEASLES MORTALITY AND VACCINE EFFICACY IN RURAL WEST AFRICAThe Lancet, 1983
- Recommendation of the Immunization Practices Advisory Committee (ACIP). Measles prevention.1982
- EPIDEMIOLOGY AND PREVENTION OF MEASLES IN RURAL SOUTH-INDIA1980
- Further attenuated live measles vaccines: The need for revised recommendationsThe Journal of Pediatrics, 1977
- Epidemic Measles in a Highly Vaccinated PopulationNew England Journal of Medicine, 1977
- Immunity to Measles in Children Vaccinated Before and After 1 Year of AgeArchives of Pediatrics & Adolescent Medicine, 1972
- Urban measles in the vaccine era: A clinical, epidemiologic, and serologic studyThe Journal of Pediatrics, 1972
- Live, Further Attenuated Rubeola VaccineAmerican Journal of Diseases of Children, 1972
- Present status of measles and rubella immunization in the United States: A medical progress reportThe Journal of Pediatrics, 1971